Amano Yuji, Uno Goichi, Yuki Takafumi, Okada Mayumi, Tada Yasumasa, Fukuba Nobuhiko, Ishimura Norihisa, Ishihara Shunji, Kinoshita Yoshikazu
Division of Endoscopy, Shimane University Hospital, Izumo, Japan.
BMC Res Notes. 2011 Oct 13;4:409. doi: 10.1186/1756-0500-4-409.
A clinical history of peptic ulcer has been reported to be associated with a high rate of ulcer recurrence in nonsteroidal anti-inflammatory drug (NSAID) users. Therefore, it is a very important issue to precisely know the previous history prior to NSAIDs administration. To clarify the possible difficulty to identify the history, we determined the sensitivity and diagnostic concordance of endoscopy for the identification of ulcer scars indicative of previous clinical history of peptic ulcer diseases.
The first study enrolled 200 consecutive patients with a clinical history of gastric or duodenal ulcers previously confirmed by esophagogastroduodenoscopy. The sensitivity of endoscopy for identifying scars was determined for these patients. In the second study, the extent of interobserver agreement was determined for 47 endoscopists who identified ulcer scars in endoscopic photographs of 30 sites of previous active gastric ulcers and 30 sites of previous active duodenal ulcers. The kappa coefficient of reliability was calculated to measure the interobserver agreement on the diagnosis of ulcer scars.
Out of 190 patients eligible for analysis, 104 (54.7%) were found to have gastric or duodenal ulcer scars on endoscopy; there were no gastric or duodenal ulcer scars seen in the remaining patients (45%). In the second study, the kappa values for endoscopic diagnosis of gastric and duodenal ulcer scars were 0.14 (95% CI 0.13-0.16) and 0.29 (95% CI 0.27-0.32), respectively. The addition of indigo-carmine chromoendoscopy did not provide a statistically significant improvement in diagnostic concordance in patients with gastric ulcer scar since the kappa value for chromoendoscopic diagnosis was 0.15; 95% CI 0.13-0.17 as low as for un-contrasted scars.
The sensitivity and concordance of endoscopic diagnosis of gastric and duodenal ulcer scars are not satisfactory for the use of endoscopy only to identify previous ulcer disease. To avoid the overlooking the previous clinical history of peptic ulcer diseases, the diagnosis of peptic ulcer scar has to be carefully done prior to NSAIDs administration.
据报道,消化性溃疡病史与非甾体抗炎药(NSAID)使用者溃疡复发率高有关。因此,在使用NSAIDs之前准确了解既往病史是一个非常重要的问题。为了阐明识别该病史可能存在的困难,我们确定了内镜检查对识别提示既往消化性溃疡疾病临床病史的溃疡瘢痕的敏感性和诊断一致性。
第一项研究纳入了200例连续的患者,这些患者既往有经食管胃十二指肠镜检查确诊的胃溃疡或十二指肠溃疡病史。确定这些患者内镜检查识别瘢痕的敏感性。在第二项研究中,对47位内镜医师进行了观察者间一致性程度的评估,这些内镜医师在30处既往活动性胃溃疡和30处既往活动性十二指肠溃疡的内镜照片中识别溃疡瘢痕。计算可靠性的kappa系数以衡量观察者间对溃疡瘢痕诊断的一致性。
在190例符合分析条件的患者中,104例(54.7%)在内镜检查中发现有胃溃疡或十二指肠溃疡瘢痕;其余患者(45%)未发现胃溃疡或十二指肠溃疡瘢痕。在第二项研究中,内镜诊断胃溃疡和十二指肠溃疡瘢痕的kappa值分别为0.14(95%CI 0.13 - 0.16)和0.29(95%CI 0.27 - 0.32)。对于胃溃疡瘢痕患者,添加靛胭脂染色内镜检查在诊断一致性方面未提供统计学上的显著改善,因为染色内镜诊断的kappa值为0.15;95%CI 0.13 - 0.17,与未染色瘢痕一样低。
仅通过内镜检查来识别既往溃疡疾病,胃溃疡和十二指肠溃疡瘢痕的内镜诊断敏感性和一致性并不令人满意。为避免忽视既往消化性溃疡疾病的临床病史,在使用NSAIDs之前必须仔细进行消化性溃疡瘢痕的诊断。